3rd Quarter - Report
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) for ASTELLAS PHARMA US, INC.
Client
Income
$30,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
General reimbursement issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN E IRIZARRY New | Counsel, Senate HELP and Sen. Chuck Hagel |
| RICHARD CHARLES WHITE New | Legislative Coordinator, Sen. John Charles |
Health Issues HCR
The Federal, Food, Drug and Cosmetic Act The Prescription Drug User Fee Act (PDUFA) Generating Antibiotic Incentives Now (GAIN) Act Patient Protection and Affordable Care Act FDA Safety & Innovation Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN E IRIZARRY New | Counsel, Senate HELP and Sen. Chuck Hagel |
| RICHARD CHARLES WHITE New | Legislative Coordinator, Sen. John Charles |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.